Bragg Financial Advisors, Inc Enovis Corp Transaction History

Bragg Financial Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$51.65 - $65.54 $164,970 - $209,334	3,194 Added 17.53%	21,414 $1.13 Million
Q2 2023 Aug 15, 2023	BUY	$52.7 - $64.12 $2,635 - $3,206	50 Added 0.28%	18,220 $1.17 Million
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $1,386 - $1,845	28 Added 0.15%	18,170 $971,000
Q4 2022 Feb 14, 2023	SELL	$44.83 - $57.43 $717 - $918	-16 Reduced 0.09%	18,142 $970,000
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $921 - $1,202	-20 Reduced 0.11%	18,158 $837,000
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $999,790 - $1.28 Million	18,178 New	18,178 $1 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Bragg Financial Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bragg Financial Advisors, Inc with notifications on news.